We are live on ! Find out more
ENZ

Enzo Biochem, Inc.

Delisted

ENZ was delisted on the 17th of April, 2025.

6 hedge funds and large institutions have $254K invested in Enzo Biochem, Inc. in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

85% less funds holding

Funds holding: 416 (-35)

95% less capital invested

Capital invested by funds: $4.96M → $254K (-$4.71M)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 36

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
6
Holders Change
-35
Holders Change %
-85.37%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
2
Reduced
1
Closed
36
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RC
1
RBF Capital
California
$102K -$32.4K -100,359 -40%
Squarepoint
2
Squarepoint
New York
$95.4K +$4.26K +13,197 +10%
XT
3
XTX Topco
Cayman Islands
$30.4K +$7.65K +23,687 +112%
KCM
4
Kempner Capital Management
Texas
$17K
GSC
5
Ground Swell Capital
South Carolina
$9.33K +$4.44K +13,761 New
HFA
6
Harbert Fund Advisors
Alabama
-$1.92M -5,175,913 Closed
Renaissance Technologies
7
Renaissance Technologies
New York
-$770K -2,082,229 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
-$688K -1,859,002 Closed
BlackRock
9
BlackRock
New York
-$354K -957,775 Closed
MBAM
10
Mink Brook Asset Management
Florida
-$299K -807,899 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
-$160K -431,042 Closed
WIM
12
Wittenberg Investment Management
Massachusetts
-$101K -274,095 Closed
Citadel Advisors
13
Citadel Advisors
Florida
-$78K -210,877 Closed
State Street
14
State Street
Massachusetts
-$62.5K -168,881 Closed
LDNAM
15
Lepercq De Neuflize Asset Management
New York
-$57.8K -156,303 Closed
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
-$51.5K -138,126 Closed
BP
17
BBR Partners
New York
-$37K -100,000 Closed
NIMC
18
Nierenberg Investment Management Company
Washington
-$32.8K -88,555 Closed
BCM
19
Bridgeway Capital Management
Texas
-$28.6K -77,200 Closed
Morgan Stanley
20
Morgan Stanley
New York
-$24.9K -67,342 Closed
Northern Trust
21
Northern Trust
Illinois
-$24.9K -67,204 Closed
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
-$22.2K -60,041 Closed
Lazard Asset Management
23
Lazard Asset Management
New York
-$18K -50,453 Closed
UBS Group
24
UBS Group
Switzerland
-$16.9K -45,713 Closed
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
-$17K -44,800 Closed

ENZ Hedge Fund Activity: Q2 2025 in Review

6 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2025, worth a combined $254K — down 95% from $4.96M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ENZ and 1 opened new positions — a net loss of 35 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $7.65K. The largest seller was Harbert Fund Advisors, exiting entirely with an estimated $1.92M sold.

  • 6 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2025, down from 41 in Q1 2025.
  • Funds reported $254K of Enzo Biochem, Inc. stock for Q2 2025, down 95% quarter-over-quarter.
  • 1 fund opened new Enzo Biochem, Inc. positions in Q2 2025 and 36 closed out, a net change of -35 holders.
  • The largest Enzo Biochem, Inc. buyer in Q2 2025 was XTX Topco, an estimated $7.65K added.
  • The largest Enzo Biochem, Inc. seller in Q2 2025 was Harbert Fund Advisors, an estimated $1.92M sold.

Based on aggregated 13F filings for Q2 2025.